TB Alliance and BioFocus sign compound management agreement
Advertisement
BioFocus announced that it has signed a three year compound management agreement with the Global Alliance for TB Drug Development (TB Alliance). Under this agreement BioFocus will manage TB Alliance’s chemical library collection. These services will be provided by BioFocus’ compound management facility in South San Francisco, USA.
Other news from the department business & finance
These products might interest you
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Xceleron and Covance enter co-promotional agreement
Researchers snap giant virus in 3-D - Study demonstrates potential of future X-ray laser investigations
New study creates first 3-D vision of cancer target
Labcyte Awarded 1st Patent in China
Common hormone could help treat breast cancer
Biogenetically inspired approach to alkaloid family
Cellectis and the Center for iPS Cells Research and Application enter collaboration
Possible cause and source of Kawasaki disease found - Deadly childhood condition may be triggered by airborne aerosols from northeast China
Decoding Lil BUB: Crowdfunded project reveals genome of internet celebrity cat